TLDR Sam Bankman-Fried claims FTX was “never insolvent.” He blames bankruptcy lawyers and CEO John J. Ray III for its downfall. The document argues FTX could have repaid customers in 2022. His family is lobbying for a Trump pardon as part of a PR campaign. Most experts dismiss the claims as an attempt to rewrite [...] The post Sam Bankman-Fried Publishes Document Claiming FTX Was Solvent appeared first on CoinCentral.TLDR Sam Bankman-Fried claims FTX was “never insolvent.” He blames bankruptcy lawyers and CEO John J. Ray III for its downfall. The document argues FTX could have repaid customers in 2022. His family is lobbying for a Trump pardon as part of a PR campaign. Most experts dismiss the claims as an attempt to rewrite [...] The post Sam Bankman-Fried Publishes Document Claiming FTX Was Solvent appeared first on CoinCentral.

Sam Bankman-Fried Publishes Document Claiming FTX Was Solvent

TLDR

  • Sam Bankman-Fried claims FTX was “never insolvent.”

  • He blames bankruptcy lawyers and CEO John J. Ray III for its downfall.

  • The document argues FTX could have repaid customers in 2022.

  • His family is lobbying for a Trump pardon as part of a PR campaign.

  • Most experts dismiss the claims as an attempt to rewrite history.


Sam Bankman-Fried, the imprisoned founder of the collapsed crypto exchange FTX, has resurfaced online with a lengthy defense document. He claims the company “was never insolvent” and could have repaid customers in full.

The 15-page statement, posted on X, argues that bankruptcy lawyers—not bad management—were responsible for destroying what he describes as a solvent but illiquid company. He accuses them of “decimating” FTX’s assets through unnecessary filings and mismanagement.

FTX “Could Have Been Worth $136 Billion”

The document, dated September 30, includes detailed tables of hypothetical valuations. It claims that FTX and its trading arm Alameda Research held $25 billion in assets and $16 billion in equity when the company collapsed in November 2022.

According to Bankman-Fried, the company’s liquidity crisis could have been resolved within weeks if outside counsel hadn’t taken control. He alleges that bankruptcy teams sold assets below market value and discarded billions in native FTT tokens, reducing overall recoveries.

The post marks the latest phase in a broader public relations effort by the former crypto mogul. His parents and legal allies are reportedly lobbying for a presidential pardon from Donald Trump. They have enlisted attorney Kory Langhofer, known for ties to the Republican Party, and even arranged media outreach through conservative channels.

Prediction market traders on Kalshi currently give Bankman-Fried about a 10% chance of receiving a pardon. Still, his renewed push on social media appears designed to shift public opinion and portray himself as a victim of legal overreach.

During his trial, Bankman-Fried was barred from presenting financial evidence supporting his solvency claims. Prosecutors argued that he illegally used customer deposits to cover losses at Alameda, violating basic trust and risk controls.

FTX’s Real Financial Picture

Court filings tell a very different story. Evidence showed that Alameda had a secret exemption from FTX’s risk engine, allowing it to borrow billions in customer funds without collateral. When this was exposed, customers rushed to withdraw their money, leaving an $8 billion hole in the balance sheet.

FTX’s 2022 collapse wiped out around $200 billion in crypto market value and triggered a regulatory crackdown worldwide. Bankman-Fried was convicted in 2023 on seven counts of fraud and conspiracy and is now serving a 25-year sentence.

The new claims, while detailed, have yet to be verified by the bankruptcy estate or independent analysts. For now, Bankman-Fried’s defense appears more like an effort to rewrite the FTX narrative than a credible financial audit.


Summary: Sam Bankman-Fried claims FTX was solvent, blaming lawyers for its downfall, but evidence suggests otherwise.

The post Sam Bankman-Fried Publishes Document Claiming FTX Was Solvent appeared first on CoinCentral.

Market Opportunity
John Tsubasa Rivals Logo
John Tsubasa Rivals Price(JOHN)
$0.00797
$0.00797$0.00797
+0.37%
USD
John Tsubasa Rivals (JOHN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23